TRIM16 Inhibits Inflammation by Interacting With and Ubiquitinating TRAF2 in a Colitis Model
Journal of Cellular and Molecular Medicine · 2025-10 · 29 (20)
DOI: 10.1111/jcmm.70917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 24.10.2025. Verfasst von Dong-Liang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First People's Hospital of Zhangjiagang City, Suzhou, China. Hauptthemen laut MEDLINE: Colitis, Ubiquitination, TNF Receptor-Associated Factor 2, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Project of Zhangjiagang Science and Technology Bureau, the Suzhou Gusu Health Talent Program.
Abstract (Originalsprache)
Tripartite motif 16 (TRIM16), an E3 ubiquitin ligase, plays crucial roles in regulating cell proliferation, differentiation, autophagy and immunity. Several studies have suggested that TRIM16 may function as an anti‐inflammatory factor in various diseases. However, the functional significance and regulatory mechanisms of TRIM16 in inflammatory bowel disease (IBD) have yet to be fully explored. This investigation examined the expression and underlying mechanisms of TRIM16 in both in vivo and in vitro models of inflammation. The expression of TRIM16 was significantly decreased in a dextran sulfate sodium (DSS)‐induced mouse colitis model and in lipopolysaccharide (LPS)‐stimulated RAW264.7 macrophages. Additionally, TRIM16 knockdown in LPS‐treated RAW264.7 cells resulted in increased mRNA levels of iNOS , TNF‐α and IL‐6 , as well as in increased activation of the NF‐ĸB signalling pathway. Mechanistically, TRIM16 interacted with tumour necrosis factor receptor‐associated factor 2 (TRAF2), facilitating its ubiquitination, which in turn impeded NF‐ĸB signalling and reduced the expression of inflammatory mediators such as IL‐6. Our in vitro and in vivo findings highlight the critical role of TRIM16 in modulating the TRAF2/NF‐ĸB signalling pathway. Furthermore, the observed downregulation of TRIM16 was correlated with the onset of colitis, suggesting that TRIM16 may serve as a promising therapeutic target for both the prevention and treatment of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First People's Hospital of Zhangjiagang City, Suzhou, China.
- Center for Translational Medicine, The First People's Hospital of Zhangjiagang City, Suzhou, China.
ORCID-Profile: Liang Ji
Förderung
- the Project of Zhangjiagang Science and Technology Bureau
- the Suzhou Gusu Health Talent Program
Zitieren
APA
Li, D. L., Zhou, L., Zhang, B., Wang, S., Liang, Q. Y., Liu, Q. H., Qu, C. J., & Ji, L. (2025). TRIM16 Inhibits Inflammation by Interacting With and Ubiquitinating TRAF2 in a Colitis Model. Journal of Cellular and Molecular Medicine, 29(20). https://doi.org/10.1111/jcmm.70917
Vancouver
Li DL, Zhou L, Zhang B, Wang S, Liang QY, Liu QH, et al. TRIM16 Inhibits Inflammation by Interacting With and Ubiquitinating TRAF2 in a Colitis Model. Journal of Cellular and Molecular Medicine. 2025;29(20). doi:10.1111/jcmm.70917
BibTeX
@article{Li2025,
author = {Li, Dong-Liang and Zhou, Li and Zhang, Bo and Wang, Shuai and Liang, Qing-Yu and Liu, Qiu-Hua and Qu, Chen-Jiang and Ji, Liang},
title = {TRIM16 Inhibits Inflammation by Interacting With and Ubiquitinating TRAF2 in a Colitis Model},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {20},
doi = {10.1111/jcmm.70917}
}
EUVIMED